Dare Bioscience (DARE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.74, +1.51% vs the prior close of $0.73.
- Volume 96.90K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DARE rises 1.5% to $0.74. Closed at $0.74, +1.51% vs the prior close of $0.73. Day range $0.72–$0.75, opened at $0.73.
DARE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DARE rises 1.5% to $0.74
- Closed at $0.74, +1.51% vs the prior close of $0.73. Day range $0.72–$0.75, opened at $0.73.
- Volume was 96.90K shares, 0.2x its 50-day average of 604.08K — lighter than usual.
- Price is -12.9% vs its 50-day average ($0.85) and -55.2% vs its 200-day average ($1.65).
- 52-week range $0.69–$3.78; today's close sits at 2% of that range, 80.4% below the 52-week high.
Oct 14, 2026 — DARE dips 2.5% to $0.73, 3 down days in a row
- Closed at $0.73, -2.54% vs the prior close of $0.75. Day range $0.72–$0.74, opened at $0.74.
- Volume was 61.00K shares, 0.1x its 50-day average of 605.54K — lighter than usual.
- Price is -15.4% vs its 50-day average ($0.86) and -56.0% vs its 200-day average ($1.66).
- 52-week range $0.69–$3.78; today's close sits at 1% of that range, 80.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DARE ends flat (-0.3%) to $0.75
- Closed at $0.75, -0.27% vs the prior close of $0.75. Day range $0.73–$0.79, opened at $0.79.
- Volume was 116.10K shares, 0.2x its 50-day average of 605.74K — lighter than usual.
- Price is -14.4% vs its 50-day average ($0.87) and -55.1% vs its 200-day average ($1.67).
- 52-week range $0.69–$3.78; today's close sits at 2% of that range, 80.2% below the 52-week high.
Oct 12, 2026 — DARE dips 3.0% to $0.75
- Closed at $0.75, -2.98% vs the prior close of $0.77. Day range $0.74–$0.79, opened at $0.77.
- Volume was 81.60K shares, 0.1x its 50-day average of 605.58K — lighter than usual.
- Price is -15.2% vs its 50-day average ($0.88) and -55.1% vs its 200-day average ($1.67).
- 52-week range $0.69–$3.78; today's close sits at 2% of that range, 80.2% below the 52-week high.
Oct 9, 2026 — DARE ends flat (+0.1%) to $0.77
- Closed at $0.77, +0.13% vs the prior close of $0.77. Day range $0.76–$0.79, opened at $0.79.
- Volume was 69.60K shares, 0.1x its 50-day average of 606.99K — lighter than usual.
- Price is -13.5% vs its 50-day average ($0.89) and -54.0% vs its 200-day average ($1.68).
- 52-week range $0.69–$3.78; today's close sits at 3% of that range, 79.6% below the 52-week high.
Oct 8, 2026 — DARE dips 2.3% to $0.77, 6 down days in a row
- Closed at $0.77, -2.28% vs the prior close of $0.79. Day range $0.75–$0.80, opened at $0.79.
- Volume was 165.80K shares, 0.3x its 50-day average of 605.35K — lighter than usual.
- Price is -14.6% vs its 50-day average ($0.90) and -54.2% vs its 200-day average ($1.69).
- 52-week range $0.69–$3.78; today's close sits at 3% of that range, 79.6% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — DARE slides 5.2% to $0.79, 5 down days in a row
- Closed at $0.79, -5.16% vs the prior close of $0.83. Day range $0.79–$0.82, opened at $0.81.
- Volume was 113.20K shares, 0.2x its 50-day average of 606.43K — lighter than usual.
- Price is -13.3% vs its 50-day average ($0.91) and -53.3% vs its 200-day average ($1.69).
- 52-week range $0.69–$3.78; today's close sits at 3% of that range, 79.1% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — DARE dips 1.2% to $0.83, 4 down days in a row
- Closed at $0.83, -1.19% vs the prior close of $0.84. Day range $0.83–$0.88, opened at $0.83.
- Volume was 88.40K shares, 0.1x its 50-day average of 608.02K — lighter than usual.
- Price is -9.4% vs its 50-day average ($0.92) and -51.0% vs its 200-day average ($1.70).
- 52-week range $0.69–$3.78; today's close sits at 5% of that range, 78.0% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: DEF 14A.
Oct 5, 2026 — DARE ends flat (+0.0%) to $0.84, 3 down days in a row
- Closed at $0.84, +0.00% vs the prior close of $0.84. Day range $0.83–$0.87, opened at $0.83.
- Volume was 157.20K shares, 0.3x its 50-day average of 608.82K — lighter than usual.
- Price is -9.2% vs its 50-day average ($0.93) and -50.6% vs its 200-day average ($1.71).
- 52-week range $0.69–$3.78; today's close sits at 5% of that range, 77.7% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — DARE dips 0.9% to $0.84
- Closed at $0.84, -0.94% vs the prior close of $0.85. Day range $0.82–$0.88, opened at $0.87.
- Volume was 147.30K shares, 0.2x its 50-day average of 609.26K — lighter than usual.
- Price is -10.1% vs its 50-day average ($0.94) and -50.8% vs its 200-day average ($1.72).
- 52-week range $0.69–$3.78; today's close sits at 5% of that range, 77.7% below the 52-week high.
- SEC filings that day: 8-K.
DARE latest news & SEC filings
Every SEC filing by or about DARE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 23, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 4, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 26, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 24, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
- Item 8.01 — Reported other events the company considers important.
Aug 17, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade DARE
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026, Nov 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.25% (largest 8.7%). That is a volatile stock.
- Liquidity: about 214.71K shares (≈$158.89K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.74 vs a range of $0.69–$3.78 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 2, 2026; 8-K Oct 1, 2026; 8-K Sep 11, 2026.
- Share count: 15.29M shares outstanding (Aug 12, 2026), +13.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
DARE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.73 | 0.75 | 0.72 | 0.74 | 96.90K |
| Oct 14, 2026 | 0.74 | 0.74 | 0.72 | 0.73 | 61.00K |
| Oct 13, 2026 | 0.79 | 0.79 | 0.73 | 0.75 | 116.10K |
| Oct 12, 2026 | 0.77 | 0.79 | 0.74 | 0.75 | 81.60K |
| Oct 9, 2026 | 0.79 | 0.79 | 0.76 | 0.77 | 69.60K |
| Oct 8, 2026 | 0.79 | 0.80 | 0.75 | 0.77 | 165.80K |
| Oct 7, 2026 | 0.81 | 0.82 | 0.79 | 0.79 | 113.20K |
| Oct 6, 2026 | 0.83 | 0.88 | 0.83 | 0.83 | 88.40K |
| Oct 5, 2026 | 0.83 | 0.87 | 0.83 | 0.84 | 157.20K |
| Oct 2, 2026 | 0.87 | 0.88 | 0.82 | 0.84 | 147.30K |
| Oct 1, 2026 | 0.86 | 0.87 | 0.83 | 0.85 | 134.80K |
| Sep 30, 2026 | 0.80 | 0.88 | 0.77 | 0.85 | 277.70K |
| Sep 29, 2026 | 0.79 | 0.87 | 0.74 | 0.81 | 644.40K |
| Sep 28, 2026 | 0.79 | 0.82 | 0.70 | 0.75 | 697.30K |
| Sep 25, 2026 | 0.77 | 0.79 | 0.75 | 0.78 | 119.10K |
| Sep 24, 2026 | 0.80 | 0.85 | 0.71 | 0.74 | 469.50K |
| Sep 23, 2026 | 0.85 | 0.87 | 0.80 | 0.81 | 99.70K |
| Sep 22, 2026 | 0.81 | 0.88 | 0.81 | 0.85 | 245.50K |
| Sep 21, 2026 | 0.82 | 0.84 | 0.80 | 0.81 | 279.90K |
| Sep 18, 2026 | 0.79 | 0.81 | 0.77 | 0.78 | 229.20K |
About Dare Bioscience
Dare Bioscience (DARE) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1401914.
DARE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jessica D. Grossman | Director | Jul 2, 2026 |
| Sabrina Martucci Johnson | Chef Executive Officer | Feb 20, 2026 |
| Susan L. Kelley | Director | Jul 2, 2026 |
| Gregory W Matz | Director | Jul 2, 2026 |
| William H Rastetter | Director | Jul 2, 2026 |
| Robin Joan Steele | Director | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mardee Haring-Layton | Chief Accounting Officer | Feb 2, 2026 |
| Sabrina Martucci Johnson | Chef Executive Officer | Feb 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
DARE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.03M | $-13.40M | -1.20 | $-9.89M |
| Dec 31, 2024 | $9.78K | $-4.05M | -0.48 | $5.47M |
| Dec 31, 2023 | $2.81M | $-30.16M | -4.15 | $-38.86M |
| Dec 31, 2022 | $10.00M | $-30.95M | -0.37 | $-18.09M |
| Dec 31, 2021 | $0 | $-38.70M | -0.63 | $-28.76M |
Latest balance sheet: total assets $22.37M, total liabilities $22.93M, cash $12.62M (as of Jun 30, 2026).
DARE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.37 |
| May 14, 2026 | 8-K Item 2.02 (results) | $2.86 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.51 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $1.89 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.07 |
| May 13, 2025 | 8-K Item 2.02 (results) | $2.89 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $2.89 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.57 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DARE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.